EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.24.7 | Abruptio Placentae |
12380602 |
Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 3.4.24.7 | Acute Coronary Syndrome |
29349668 |
Serum MMP-9 Diagnostics, Prognostics, and Activation in Acute Coronary Syndrome and Its Recurrence. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
2
3
0 |
| 3.4.24.7 | Acute Lung Injury |
9181053 |
Matrix metalloproteinases and lung injury. |
causal interaction
unassigned |
4
0 |
| 3.4.24.7 | Adenocarcinoma |
7485393 |
Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
3
1 |
| 3.4.24.7 | Adenocarcinoma |
8362969 |
Interstitial collagenase gene expression in colonic neoplasia. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
2
0 |
| 3.4.24.7 | Adenocarcinoma |
9062392 |
Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
1
0 |
| 3.4.24.7 | Adenocarcinoma |
9736043 |
Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
4
1 |
| 3.4.24.7 | Adenocarcinoma |
10547569 |
Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
3
4 |
| 3.4.24.7 | Adenocarcinoma |
10914717 |
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
1 |
| 3.4.24.7 | Adenocarcinoma |
10989641 |
Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation. |
causal interaction
unassigned |
4
0 |
